DEEP DIVE / AVOIDING OVERDIAGNOSIS
Start with the clinical problem
A highly sensitive PCR can find an organism without proving it is responsible for symptoms. The European position statement discourages routine testing and treatment of U. parvum, U. urealyticum and M. hominis, including indiscriminate testing of symptomatic adults. The useful next step is a targeted evaluation, not automatic eradication of every detected species. [08]
| Finding / context | Preferred interpretation and action |
|---|---|
No symptoms; isolated positive result | Usually colonization; routine antibiotics or repeated clearance tests are not supported |
Persistent urethritis | Assess established STIs, treatment history and other causes first; selected high-load U. urealyticum may warrant specialist consideration |
Vaginal symptoms or cervicitis | Evaluate established causes, including bacterial vaginosis when relevant; Ureaplasma detection alone is not a causal diagnosis |
Neonatal illness, major immune suppression or selected pregnancy complications | Specialist context; do not generalize these risks to uncomplicated adult carriage |
Species names are clinically important
M. genitalium, M. hominis and Ureaplasma species are not interchangeable. They differ in evidence of disease, clinical indications and antibiotic susceptibility. A report reading only "mycoplasma" needs clarification before treatment or partner notification. Even within Ureaplasma, U. parvum and U. urealyticum should not automatically be assigned the same causal significance. [08][09][10][11]
Why a test-to-zero strategy can be counterproductive
Repeated antibiotics can cause adverse effects, disturb other microbial communities and select resistance without demonstrated benefit. A follow-up positive result may still be colonization, rather than treatment failure that requires another course. SSI specifically cautions that these organisms may persist as part of the flora and does not recommend routine eradication checks. [08][09]
How to communicate an incidental result
Use accurate terminology: "Ureaplasma was detected" is different from "a partner was exposed to a disease that requires treatment." There is no standard notification window or presumption that every partner needs a test. When symptoms or a specialist diagnosis change the clinical significance, the clinician can advise targeted communication. [08][09]
This section concerns general adult sexual-health decisions. It is not guidance for neonatal care, invasive infection, obstetric complications or immunocompromised patients.